In 2000, the World Health Organization ranked Colombia first in the world for fairness of financial contribution to health. Many observers were surprised. Seven years earlier, only about a quarter of Colombians had any health insurance. Care for the poor depended on underfunded public hospitals, charity and whatever families could pay out of pocket.

The change came from Law 100 of 1993, one of the most ambitious health reforms ever attempted in a middle-income country. Colombia did not adopt a Bismarckian social insurance model or a Beveridge-style national health service. It built something closer to Alain Enthoven's managed competition, adapted to a society where most workers operated outside the formal economy. Juan Luis Londoño, the health minister who steered the reform, later gave the approach a name with Julio Frenk: structured pluralism.

The design rested on a deceptively simple idea: one system, two funding streams, and competing insurers serving everyone. Formal workers would pay in through payroll contributions. The poor would be enrolled through public subsidy. Private, public and mixed insurers would compete for both groups. Three decades on, Colombia offers one of the clearest natural experiments in whether market structures can serve universal coverage goals, and where they begin to strain.

One System, Two Regimes: How the Pieces Connect

Law 100 created the General System of Social Security in Health, known as the SGSSS, with two regimes under one roof. The contributory regime covers formal employees, pensioners and independent workers who can pay. The subsidised regime covers people without payment capacity. These people are identified through SISBEN, a proxy means test that scores households on living conditions rather than on reported income, which is unreliable in informal economies.

Contributory members pay 12.5% of their wages. The cost has historically been split between employer and employee, and independent workers contribute on a defined portion of their earnings. These contributions do not go to the insurer directly. They flow into a central fund: originally FOSYGA, and since 2017 ADRES, a single administrator that pools resources and pays insurers a risk-adjusted capitation known as the UPC.

A solidarity transfer links the two regimes. Up to one and a half percentage points of every contributory payment are earmarked for the subsidised regime, alongside general taxation and intergovernmental transfers to municipalities. Formal workers explicitly cross-subsidise informal and poor households. Making redistribution this visible, rather than burying it in general revenue, was a deliberate political and institutional choice.

For years, integration existed more on paper than in practice. The original subsidised benefits package was roughly half the size of the contributory one, and the capitation paid for subsidised members was considerably lower. In 2008, the Constitutional Court's landmark ruling T-760 ordered the two packages unified. Unification proceeded in stages, first for children and then for older adults, and covered the entire population by 2012.

Later rules on mobility allowed people to move between regimes as their employment status changed, without switching insurer. This matters enormously in economies where workers cycle in and out of formal jobs, sometimes several times a year. Coverage follows the person rather than the payslip, and a lost job no longer means a broken relationship with the care network.

Takeaway

Colombia's most important act of integration was less about pooling money than about letting people move between funding streams without losing their insurer. In high-informality economies, continuity across changes in employment may matter more than the generosity of either regime.

What Insurers Compete On When Price Is Fixed

The insurers at the centre of the system are the EPS, or Entidades Promotoras de Salud. They enrol members, assemble networks of providers (IPS), manage care and bear financial risk. They take many institutional forms: some are private companies, some public or mixed entities, and others cooperatives or family compensation funds. Each EPS receives a fixed capitation per enrollee, adjusted for age, sex and geography.

Contribution rates and the benefits package are both set centrally, so EPS cannot compete on premiums or on what they cover. In theory, competition takes place on the dimensions Enthoven emphasised: network quality, access, service and efficiency. Members can switch insurer after a minimum enrolment period. The premise is that dissatisfied patients will leave, and that their exit will discipline poor performers.

In practice, the incentives often point in less flattering directions. Demographic risk adjustment captures little of true health status. Insurers can therefore profit by attracting healthy members and quietly deterring expensive ones through narrow networks, administrative friction and authorisation delays. In 2007, Colombia responded with the Cuenta de Alto Costo, a mechanism that redistributes funds among insurers according to their burden of costly conditions such as chronic kidney disease and HIV.

Vertical integration added another layer of complexity. Many EPS built or acquired their own hospitals and clinics, which raised concerns that insurers were steering spending towards affiliated facilities. Legislation in 2007 capped the share of spending an EPS could direct to its own providers at 30%. Meanwhile, insurers' slow payments to independent hospitals became chronic, and provider debt became one of the system's defining pathologies.

The market has also proved fragile. Saludcoop, once the largest EPS, was liquidated in 2015 after regulators found that health resources had been diverted, and several of its successor entities struggled. Enrolment has gradually concentrated among fewer insurers. Government interventions in failing EPS have become common. Whether EPS should remain risk-bearing insurers or become administrative managers is now the central question of Colombian health politics.

Takeaway

When price and benefits are fixed, competition does not disappear. It migrates to whatever margins remain, including risk selection and payment delays, so the regulator's real task is deciding which margins insurers are allowed to compete on.

Universal Enrolment, Unfinished Access

On enrolment, the results are hard to dispute. Insurance coverage rose from roughly a quarter of the population in 1993 to more than 95% within about two decades. Roughly half of Colombians now sit in the subsidised regime. This reflects persistent labour informality rather than a failure of the model, and it shows how far public subsidy had to reach to make universality possible.

Financial protection is the system's quiet triumph. Out-of-pocket payments account for around 15% of current health expenditure, among the lowest shares in Latin America and below many high-income countries. Research has linked expansion of the subsidised regime to greater use of preventive and curative services among poorer households, and to fewer families facing catastrophic health spending.

Yet insurance is not access. An EPS card does not guarantee a specialist appointment in Chocó or La Guajira, where networks are thin, distances are vast and providers are scarce. Rural, Afro-Colombian and Indigenous populations face waiting times and service gaps that national averages obscure. Colombia illustrates a pattern common to coverage expansions everywhere: financial coverage grows faster than the supply of care it is meant to purchase.

The most distinctive symptom is the tutela, a constitutional writ that lets citizens petition judges directly to protect fundamental rights. In many years, well over a hundred thousand health-related tutelas have been filed, often for services already in the benefits package that insurers delayed or denied. In 2015, a Statutory Law declared health a fundamental right. It shifted the system towards broad entitlement with explicit exclusions, replacing the earlier positive list of covered services.

That expansion of rights has collided with fiscal reality. Capitation rates have struggled to keep pace with costs, insurers report recurring losses, and arrears to providers persist. The system also carries a structural tension. Generous subsidised coverage may weaken incentives to formalise employment, yet formal employment is the base that funds the solidarity transfer. Colombia has achieved universal enrolment, but sustaining universal access remains unfinished work.

Takeaway

Coverage is an enrolment statistic, while access depends on the supply of care and on how well the system is governed. Colombia shows that a country can solve the first decisively and still spend decades working on the second.

Colombia's reform demonstrates that a middle-income country with high informality can reach near-universal financial protection within a generation. Its core insight remains powerful: when the same insurers serve rich and poor alike, the system avoids the two-tier segregation common across the region.

But the experience also shows that regulated competition requires regulatory capacity at least as sophisticated as the market it governs. Risk adjustment, payment discipline, network adequacy and insurer solvency each demand constant attention. A gap in any one of them quickly reshapes how every actor behaves.

For system designers elsewhere, the lesson is less about whether to use competing insurers and more about where to place the guardrails. Unified benefits, portability across funding streams and strong supervision did more for equity than competition itself. In the end, the structure around the market mattered more than the market.